Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

2.79
Delayed Data
As of 12:39pm ET
 -0.06 / -2.11%
Today’s Change
2.68
Today|||52-Week Range
18.78
-79.44%
Year-to-Date
Why ImmunoGen, Inc. Bounded Higher Today
Jul 18 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close2.85
Today’s open2.87
Day’s range2.79 - 2.94
Volume295,329
Average volume (3 months)1,921,928
Market cap$248.2M
Dividend yield--
Data as of 12:39pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)+14.46%
Earnings growth (this year)-116.28%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+42.82%
P/E ratioNM
Price/Sales14.46
Price/Book7.03

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...-0.37-3.32%
SYRSSyros Pharmaceutical...+1.00+8.73%
NSTGNanoString Technolog...-0.17-1.27%
CYADCelyad SA+1.44+5.91%
Data as of 12:52pm ET, 07/25/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$85.5M
Annual profit (last year)-$60.7M
Net profit margin-71.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs